We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
(+8.6%)
Cap. Flow
-$440M
Cap. Flow
% of AUM
-4.14%
Top 10 Holdings %
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$240M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$151M |
| 3 |
Boston Scientific
BSX
|
+$121M |
| 4 |
Amazon
AMZN
|
+$104M |
| 5 |
TransUnion
TRU
|
+$81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$166M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$132M |
| 3 |
Agilent Technologies
A
|
+$122M |
| 4 |
Accenture
ACN
|
+$73.3M |
| 5 |
Stellantis
STLA
|
+$71.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 22.87% |
| 2 | Healthcare | 20.58% |
| 3 | Financials | 10.9% |
| 4 | Technology | 10.13% |
| 5 | Industrials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Spyre Therapeutics
SYRE
$8.87B
| $3.03M | 0.03% |
+15,036
| New | +$3.13M |
|
627
Air Products & Chemicals
APD
$66.3B
| $3.02M | 0.03% |
15,825
-79,758
| -83% | -$13.7M |
|
|
TWO
628
Two Harbors Investment
TWO
$1.27B
| $3.02M | 0.03% |
+55,825
| New | +$3.13M |
|
629
Coty
COTY
$2.33B
| $3M | 0.03% |
261,290
+8,699
| +3% | +$82.3K |
|
630
Intel
INTC
$466B
| $3M | 0.03% |
55,870
-155,432
| -74% | -$7.88M |
|
631
Mitek Systems
MITK
$762M
| $3M | 0.03% |
245,032
+80,342
| +49% | +$901K |
|
632
Honeywell
HON
$77.1B
| $2.99M | 0.03% |
19,946
-69,399
| -78% | -$9.7M |
|
633
Corcept Therapeutics
CORT
$10.2B
| $2.97M | 0.03% |
252,981
-320,855
| -56% | -$3.99M |
|
|
DRNA
634
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.96M | 0.03% |
+202,213
| New | +$2.32M |
|
635
American Superconductor
AMSC
$1.48B
| $2.96M | 0.03% |
+230,225
| New | +$3.13M |
|
636
Rigel Pharmaceuticals
RIGL
$680M
| $2.95M | 0.03% |
114,640
+81,023
| +241% | +$1.85M |
|
|
ARRY
637
DELISTED
Array Biopharma Inc
ARRY
| $2.94M | 0.03% |
120,745
-44,559
| -27% | -$928K |
|
638
First Bancorp
FBNC
$2.6B
| $2.94M | 0.03% |
84,603
+79,110
| +1,440% | +$2.9M |
|
639
Appian
APPN
$1.74B
| $2.92M | 0.03% |
+84,841
| New | +$2.87M |
|
640
Kadant
KAI
$3.69B
| $2.88M | 0.03% |
32,687
-23,197
| -42% | -$2M |
|
641
Douglas Dynamics
PLOW
$1.07B
| $2.88M | 0.03% |
+75,556
| New | +$2.81M |
|
|
REGI
642
DELISTED
Renewable Energy Group, Inc.
REGI
| $2.87M | 0.03% |
130,664
+84,190
| +181% | +$2.17M |
|
|
GG
643
DELISTED
Goldcorp Inc
GG
| $2.87M | 0.03% |
+250,718
| New | +$2.69M |
|
644
Biogen
BIIB
$29.9B
| $2.81M | 0.03% |
11,906
+485
| +4% | +$153K |
|
|
WCG
645
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.8M | 0.03% |
10,381
-15,631
| -60% | -$4.04M |
|
|
LKFT
646
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $2.8M | 0.03% |
23,767
-69,991
| -75% | -$7.06M |
|
|
NXGN
647
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.8M | 0.03% |
166,205
+91,967
| +124% | +$1.59M |
|
|
CADE
648
DELISTED
Cadence Bank
CADE
| $2.77M | 0.03% |
+98,088
| New | +$2.91M |
|
649
e.l.f. Beauty
ELF
$4.56B
| $2.76M | 0.03% |
260,598
-151,805
| -37% | -$1.35M |
|
650
Arcos Dorados Holdings
ARCO
$1.73B
| $2.75M | 0.03% |
393,654
-404,945
| -51% | -$3.29M |
|
Similar funds
Marshall Wace's Q1 2019 Portfolio in Review
As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.
- Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
- Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
- Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
- Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
- Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
- Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
- Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.
Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.